Background: Paracetamol (PCM) is an effective analgesic and antipyretic when used in recommended doses. The World Health Organization (WHO) has recommended PCM as a first line antipyretic in many conditions including dengue fever (DF) or dengue hemorrhagic fever (DHF). Liver is one of the major organs affected in dengue infection. As PCM is metabolized in the liver, prescription of PCM in dengue infection may result in further deterioration of liver dysfunction. The aim of this study is to investigate the effect of PCM together with different dengue serotypes in Human Chang liver cells based on the liver enzyme activity.Methods: The MTT assay was first used to determine the 50% cytotoxicity (IC50) of PCM on Human Chang liver cells before investigating the effect of PCM on the cells infected with dengue viruses. Human Chang liver cells were then incubated with the four dengue serotypes followed by adding the predetermined level of IC50 of PCM for 24 hours. Healthy cells (non-infected and non-treated) was used as a control. The level of aspartate transaminase (AST) and alpha Glutathione-S-transferase 1 (GSTA1) were determined in the incubation mixture.Results: In the order of increasing AST cytotoxicity level, DENV-4 (23.5%), DENV-1 (37%), DENV-3 (44%) and DENV-2 (50%) was documented. For the non-infected cells (PCM alone), the AST level was 12%. Findings showed no significant difference in AST levels in infected cells as compared to control except for DENV-2 (<0.05) and DENV-3 (<0.05). There has been no significant difference in AST level when compared between the four serotypes. For GSTA1, the study showed no significant difference in levels of the four serotypes with 0.66 ug/ml (DENV-1), 0.64 ug/ml (DENV-2), 0.64 ug/ml (DENV-3), 0.70 ug/ml (DENV-4) and 0.76 ug/ml (noninfected) as compared to control with 1.88ug/ml. Conclusion:There are four dengue serotypes which infect the liver cells and elevates AST, the differences in the percentage of elevation between serotypes is not significant. GSTA1 is not a suitable marker for liver cytotoxicity in dengue infection as compared to AST in our study as AST is found to be more specific.
Objectives To evaluate the ACE inhibitory activity of protein hydrolysates derived from lupin Methods Methods used are spectrophotometer to assay the ACE activity, electrophoresis for estimation of protein molecular weight, and HPLC for determining products of ACE activity. Results The results revealed that the lupin flour was abundant in protein (43.3 g/100 g). Results from sequential Osborne extraction procedure showed that lupin protein comprised of 46% salt-soluble globulin, 27% water-soluble albumin, 18% alkaline-soluble glutelin and 7% alcohol-soluble prolamin fractions. Furthermore, lupin protein was rich in lysine but limiting in methionine. Hydrolysates prepared using Alcalase exhibited higher ACE inhibitory activities compared with those prepared using Flavourzyme, showing IC50 values ranging from 0.10 to 0.21 mg/mL. However, there was no significant difference in IC50 values between the hydrolysates prepared using Alcalase for 4, 10 and 16 h of hydrolysis times. Conclusions The results suggested that globulin was the major contributing protein fraction on ACE inhibitory effect in lupin protein. The lupin protein hydrolysates with potent ACE inhibitory activities can be incorporated into the daily diet to prevent hypertension. Funding Sources Ministry of Education Malaysia.
No abstract
From Surana Lab protocols This protocol is suitable for extracting DNA from either human or mouse feces. Best results will be obtained with 10-60 mg of starting material
A brief protocol for electrotransformation of Clostridium species
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.